Targeting European allies won't fix any of our problems with China, or improve health care, writes Josh Steuterman.

Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as ...

President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...

South Koreans’ perceptions of the US have taken a dive amid Trump’s ‘America First’ foreign policy and trade agenda.

The Singapore dollar is under renewed pressure as US trade challenges are primed to worsen and as speculation of ...

By K Raveendran The Trump administration’s twin-pronged approach to force India into granting greater trade concessions marks ...

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

The deadline on US pharmaceutical tariffs has been dramatically brought forward, in the latest escalation of Donald Trump's ...

President Donald Trump’s tariff strategy is less about trade and more about geopolitical blackmail. By refusing to be rushed ...

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.